Lionel Adès

837 total citations
11 papers, 195 citations indexed

About

Lionel Adès is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Lionel Adès has authored 11 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Hematology and 2 papers in Genetics. Recurrent topics in Lionel Adès's work include Acute Myeloid Leukemia Research (7 papers), Retinoids in leukemia and cellular processes (6 papers) and Protein Degradation and Inhibitors (3 papers). Lionel Adès is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Retinoids in leukemia and cellular processes (6 papers) and Protein Degradation and Inhibitors (3 papers). Lionel Adès collaborates with scholars based in France, United States and Switzerland. Lionel Adès's co-authors include Pierre Fenaux, Cécile Bally, Jacqueline Lehmann‐Che, Hugues de Thé, Julien Mozziconacci, Claude Preudhomme, Virginie Éclache, Aline Renneville, Arnaud Pigneux and Bruno Cassinat and has published in prestigious journals such as Nature Communications, Blood and British Journal of Haematology.

In The Last Decade

Lionel Adès

9 papers receiving 195 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lionel Adès France 5 158 110 41 33 23 11 195
Hans‐Joachim Tischler Germany 4 156 1.0× 66 0.6× 46 1.1× 34 1.0× 45 2.0× 4 186
Hans‐Günter Derigs Germany 5 106 0.7× 61 0.6× 31 0.8× 39 1.2× 43 1.9× 8 164
Afaf E.G. Osman United States 7 121 0.8× 93 0.8× 65 1.6× 27 0.8× 13 0.6× 20 201
Andrew J. Menssen United States 7 172 1.1× 69 0.6× 64 1.6× 26 0.8× 30 1.3× 18 198
Jennie B. Feliu United States 6 137 0.9× 107 1.0× 29 0.7× 40 1.2× 92 4.0× 6 219
Jasleen K. Randhawa United States 6 142 0.9× 93 0.8× 66 1.6× 19 0.6× 12 0.5× 15 178
Gabriela Borsaru Romania 7 111 0.7× 105 1.0× 28 0.7× 38 1.2× 9 0.4× 11 169
Lene Hyldahl Ebbesen Denmark 8 152 1.0× 100 0.9× 77 1.9× 24 0.7× 19 0.8× 13 215
Rossella Ribolla Italy 8 146 0.9× 105 1.0× 18 0.4× 72 2.2× 20 0.9× 21 183
Desiree De Lange Netherlands 3 147 0.9× 67 0.6× 40 1.0× 15 0.5× 78 3.4× 5 190

Countries citing papers authored by Lionel Adès

Since Specialization
Citations

This map shows the geographic impact of Lionel Adès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lionel Adès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lionel Adès more than expected).

Fields of papers citing papers by Lionel Adès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lionel Adès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lionel Adès. The network helps show where Lionel Adès may publish in the future.

Co-authorship network of co-authors of Lionel Adès

This figure shows the co-authorship network connecting the top 25 collaborators of Lionel Adès. A scholar is included among the top collaborators of Lionel Adès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lionel Adès. Lionel Adès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zhao, Lin‐Pierre, Vincent Jachiet, Olivier Kosmider, et al.. (2025). Very long-term remission with azacitidine in VEXAS syndrome. Haematologica. 110(6). 1432–1435. 1 indexed citations
2.
Adès, Lionel, Thomas Cluzeau, Thibault Comont, et al.. (2024). Combining ESA and Luspatercept in Non-RS MDS Patients Having Failed ESA - Results of the Phase 1-2 Part a of the GFM Combola Study. Blood. 144(Supplement 1). 351–351. 3 indexed citations
3.
Garcia‐Manero, Guillermo, Maciej Kaźmierczak, Agnieszka Wierzbowska, et al.. (2024). Pracinostat combined with azacitidine in newly diagnosed adult acute myeloid leukemia (AML) patients unfit for standard induction chemotherapy: PRIMULA phase III study. Leukemia Research. 140. 107480–107480. 7 indexed citations
5.
Adès, Lionel, et al.. (2023). AML-160 Unusual Side Effect of Arsenic Trioxide (ATO) in Acute Promyelocytic Leukemia (APL): A Case Report. Clinical Lymphoma Myeloma & Leukemia. 23. S274–S274.
6.
Adès, Lionel, Xavier Thomas, Emmanuel Raffoux, et al.. (2018). Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group. Haematologica. 103(12). 2033–2039. 21 indexed citations
7.
Jacoby, Meagan A., Eric J. Duncavage, Christopher A. Miller, et al.. (2018). Exome analysis of treatment‐related AML after APL suggests secondary evolution. British Journal of Haematology. 185(5). 984–987. 1 indexed citations
9.
Lehmann‐Che, Jacqueline, Cécile Bally, Éric Letouzé, et al.. (2018). Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia. Nature Communications. 9(1). 2047–2047. 33 indexed citations
10.
Bally, Cécile, Jacqueline Lehmann‐Che, Bruno Cassinat, et al.. (2016). Whole Exome Analysis of Relapsing Patients with Acute Promyelocytic Leukemia. Blood. 128(22). 2892–2892. 1 indexed citations
11.
Bally, Cécile, Lionel Adès, Aline Renneville, et al.. (2014). Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine. Leukemia Research. 38(7). 751–755. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026